The family of an Italian woman who died a few weeks after the Oxford-AstraZeneca coronavirus vaccine told Sky News that they were taking legal action to determine whether the culprit was guilty.
The case comes after she was received by 55-year-old Augusta Turiaco from Messina in Sicily COVID a sting on March 11 before her condition worsened in the days after vaccination.
The music teacher was eager to receive the blow while working with the youth, she even expressed joy over the dose in a Facebook post, writing “fatto” – the Italian word for “done”.
Although she felt bad afterwards, she returned to work, announcing two days later to calm her worried friends by saying, “Andra tutto bene” – “everything will be fine”.
Unfortunately, it was not.
She developed a high fever and a very bad headache, before going for blood tests and finally scans that identified blood clots.
She fell into a coma on March 28 and died on March 30 – 19 days after she had AstraZeneca injection.
Her brother Nunzio Turiaco told Sky News: “For us, it was like there was such a clinical picture.
“My sister was in excellent health, she didn’t take drugs because she didn’t have diseases like hypertension or diabetes.”
Medical records seen by Sky News show that blood clots had formed in Ms. Turiaco’s body, including in her brain.
Her platelet count dropped.
These are the conditions of others who died after the Oxford-AstraZeneca vaccine.
Family-initiated legal proceedings are just one in a series of cases across Europe against AstraZeneca.
Family lawyer Daniela Agnello told Sky News: “Ms. Turiaco’s excellent health, the absence of previous pathologies, a very short period of time between the vaccine, the appearance of the first diseases and very serious clinical pictures, and then death.
Subscribe to the daily podcast at Apple Podcasts, Google Podcasts, Spotify, Spreaker
“We believe that all of these are precise, serious and consistent clues to seek judicial investigations and to establish any direct or indirect, causal responsibilities that led to the death.”
Our request for an interview with AstraZenec was denied. European Medicines Agency (EMA) has now changed the advice say that unusual blood clots should be identified as a very rare side effect of the vaccine.
Immunologist, Professor Michel Goldman, who is president of the Institute for Health Innovation in Brussels, said scientific work must be carried out to determine who is most at risk and why.
But he stressed that all vaccines have a balance of risks and benefits, and cases of blood clots after the AstraZeneca vaccine are extremely unusual.
“This risk was completely unpredictable and there are precedents in the history of vaccines,” he said.
“You know, some very, very rare events can’t be predicted by animal studies, they can’t be predicted even when thousands of people are involved in clinical trials.
“Sometimes you need to give a cure to millions of people before a very small number of cases happen.”
Professor Goldman continued, “I think it’s always important to understand how rare these events are – one in 100,000.
“And you have to balance this with a very high risk of getting it coronavirus, to be hospitalized for it, to end up in an intensive care unit. “
The Oxford-AstraZeneca vaccine is still used in much of Europe, but publicity about blood clots has affected confidence in it.
Denmark became the first country to announce that it would cease to make full use of it.
Other countries have suspended the use of the vaccine while studies are being conducted, and some countries, including the UK, now limit its use to certain age groups.
Ms. Turiaco’s family insists they support the European vaccination program, but say they want to know what happened to her to ensure no one else dies after the treatment was created to protect them.
Her brother Nunzio said it was important to remember those who died.
“These are people, mothers, someone’s daughters and someone’s sisters,” he said.